Incidencia de endocarditis infecciosa en un servicio de neonatología centro de referencia nacional en el período 2009-2019 / Incidence of infective endocarditis in a national reference neonatology department in 2009-2019 / Incidência de endocardite infecciosa no departamento de neonatologia de referência nacional no período 2009-2019

La endocarditis infecciosa es una enfermedad rara en pediatría, principalmente en la etapa neonatal pero con una importante morbimortalidad. Existen factores de riesgo definidos, sin embargo el diagnóstico, principalmente en recién nacidos, continúa siendo un desafío. En este trabajo se presenta un relevamiento en 10 años, 5 casos de endocarditis infecciosa confirmada en recién nacidos y se analizan las características clínicas, estudios paraclínicos, agentes infeccioso, tratamiento realizado y asociación con factores de riesgo en esta población.

Infective endocarditis is a rare disease in pediatrics, mainly in neonates, even though it involves significant morbidity and mortality. There are defined risk factors; however, regarding diagnosis and mainly for the case of newborns, it continues to be a challenge. In this paper, we present a 10-year research and follow-up of 5 confirmed cases of infective endocarditis in newborns and their clinical characteristics, paraclinical studies, infectious agents, treatment and association with risk factors in this population

A endocardite infecciosa é uma doença rara em pediatria, principalmente na fase neonatal, mas apresenta significativa morbidade e mortalidade. Existem fatores de risco definidos, porém o diagnóstico, principalmente em recém-nascidos, continua sendo um desafio. Este paper apresenta uma pesquisa de 10 anos de 5 casos de endocardite infecciosa confirmada em recém-nascidos e analisa as suas características clínicas, estudos para clínicos, agentes infecciosos, tratamento e associação com fatores de risco nesta população.

Caracterización de los niños hospitalizados con endocarditis infecciosa en un Centro Pediátrico de Referencia de Uruguay, 2011-2018 / Characterization of children hospitalized with infective endocarditis in a Pediatric Reference Center of Uruguay, 2011-2018

Resumen Introducción: La endocarditis infecciosa (EI) es causa importante de morbimortalidad. En los últimos años se han visto cambios en la epidemiología de esta enfermedad. Objetivo: Describir las características epidemiológicas, clínicas y microbiológicas de pacientes con diagnóstico de EI ingresados en un hospital pediátrico de 2011 al 2018. Pacientes y Método: Estudio observacional, descriptivo, retrospectivo. Se incluyeron pacientes bajo 15 años de edad, hospitalizados con EI en un hospital pediátrico de referencia de Uruguay. Se utilizaron cálculos de medidas de tendencia central y dispersión, así como frecuencias absolutas y porcentuales. Resultados: Se identificaron 11 niños, media de edad 4 años 6 meses (rango 5 meses - 13 años). Cinco sin factores de riesgo, seis con factores de riesgo: cinco con cardiopatía congénita (2 con cirugía cardíaca) y uno con catéter venoso central. En 11 se obtuvo hemocultivo previo a la antibioterapia, en 10 una sola muestra, en uno hubo dos muestras. En nueve casos se recuperó el microorganismo causal; Staphylococcus aureus en cuatro (dos cepas resistentes a meticilina), seguido de Streptococcus grupo viridans tres niños. En 10 niños se encontraron vegetaciones en el ecocardiograma, seis valvulares. El tratamiento empírico más frecuente fue ceftriaxona y vancomicina. Las complicaciones fueron falla cardiaca y embolias sépticas. Cinco niños requirieron cirugía cardíaca. Falleció un paciente. Conclusiones: Se observó un aumento de EI en niños sin cardiopatía, por tanto, es necesario tener alta sospecha clínica en pacientes febriles. Importante es realizar hemocultivos previos al inicio de la antibioterapia y contemplar una cobertura contra Staphylococcus aureus en la terapia empírica inicial.

Abstract Background: Infective endocarditis (IE) is an important cause of morbidity and mortality. In recent years there have been changes in the epidemiology of this disease. Aim: To describe epidemiological, clinical and microbiological characteristics of patients with a diagnosis of IE admitted to a pediatric hospital from 2011 to 2018. Methods: Observational, descriptive, retrospective study. Children under 15 years of age hospitalized with IE in a reference pediatric hospital in Uruguay were included. Calculations of measures of central tendency and dispersion were used, as well as absolute and percentage frequencies. Results: 11 children were identified, mean age 4 years 6 months (range 5 months - 13 years). Five without risk factors, 6 with risk factors: 5 congenital heart disease (2 with cardiac surgery) and 1 central venous catheter. In 11 blood cultures were obtained prior to antibiotics, 10 a single sample, 1 with two samples. In 9 cases a microorganism was isolated. The most frequent was Staphylococcus aureus 4 children (2 methicillin resistant), followed by group viridans Streptococcus 3 children. In 10 children vegetations were found in the echocardiogram, 6 valvular. The most frequent empirical treatment was ceftriaxone and vancomycin. Complications were heart failure and septic emboli. 5 children required heart surgery. One patient died. Conclusions: An increase of IE in children without heart disease has been observed, then, it is necessary to have high clinical suspicion in febrile patients. It is important to perform blood cultures prior to the start of antibiotics and to consider coverage against Staphylococcus aureus in empirical initial treatment.

Valor do ecocardiograma na Endocardite Infecciosa associada aos dispositivos cardíacos implantáveis / Use of echocardiography in Infectious Endocarditis associated with implantable cardiac devices

Nas últimas décadas, o aumento das indicações para dispositivos cardíacos eletrônicos implantáveis tem sido acompanhado pela elevação dos casos de complicações relacionadas ao seu uso, dentre elas a endocardite infecciosa. Apesar dos avanços diagnósticos e terapêuticos da doença, esta mantém elevada morbimortalidade. Os casos relacionados aos dispositivos apresentam importantes limitações referentes aos critérios e aos métodos diagnósticos que implicam na tomada de decisão terapêutica sobre retirada do dispositivo, com risco de morte e outras complicações. Ainda assim, o ecocardiograma mantém um grande valor no diagnóstico da endocardite infecciosa relacionada a dispositivos cardíacos e de suas complicações. O entendimento das limitações e dos desafios acerca do diagnóstico reforça a necessidade de mais estudos sobre do tema. O presente artigo visa descrever a epidemiologia, a microbiologia, os fatores de risco, a patogenia, o diagnóstico e o tratamento da endocardite infecciosa associada aos dispositivos cardíacos eletrônicos implantáveis, visando demonstrar, principalmente, o valor dos exames de imagem na abordagem dessa condição clínica, com ênfase nos achados ao ecocardiograma.

In recent decades, the increase in indications for implantable electronic cardiac devices has been accompanied by an increase in cases of complications related to their use, including infectious endocarditis. Despite the diagnostic and therapeutic advances of the disease, it maintains high morbidity and mortality. The cases related to the devices have important limitations regarding the criteria and diagnostic methods that imply in making a therapeutic decision about removing the device, with risk of death and other complications. Still, echocardiography remains of great value in the diagnosis of infective endocarditis related to cardiac devices and their complications. Understanding the limitations and challenges regarding diagnosis reinforces the need for further studies on the topic. This article aims to describe the epidemiology, microbiology, risk factors, pathogenesis, diagnosis and treatment of infective endocarditis associated with implantable electronic cardiac devices, aiming to demonstrate, mainly, the value of imaging tests in addressing this clinical condition , with emphasis on echocardiogram findings.

Endocarditis tardía en un portador de un Amplatzer: Manejo conservador en un paciente pediátrico / Late onset endocarditis in Amplatzer carrier: Conservative management in a pediatric patient

Desde su aparición, las técnicas percutáneas han ido sustituyendo la cirugía convencional como tratamiento de primera línea en los defectos septales interauriculares. Los dispositivos Amplatzer fueron los primeros aprobados por la Food and Drug Administration, y su colocación se ha convertido en un procedimiento habitual en cardiología pediátrica. La aparición de endocarditis bacteriana sobre este tipo de dispositivos es muy infrecuente. Se presenta el caso de una endocarditis bacteriana en un paciente pediátrico portador de un dispositivo Amplatzer, que se manejó de forma conservadora con antibioterapia intravenosa, con evolución satisfactoria.

Since their introduction, percutaneous techniques have been replacing conventional surgery as a first-line treatment for septal defects. Amplatzer devices were the first to be approved by the Food and Drug Administration, and their placement has become a standard procedure in pediatric cardiology. Bacterial endocarditis of intracardiac devices such as the Amplatzer septal occluder is very infrequent. We report a case of bacterial endocarditis in a pediatric patient with an Amplatzer device, who developed an infectious endocarditis six years after its placement and received conservative management with intravenous antibiotics, with satisfactory evolution.

Endocarditis infecciosa en Argentina: ¿qué aprendimos en los últimos 25 años? / Infective endocarditis in Argentina: what have we learned in the last 25 years ?

La epidemiología de la endocarditis infecciosa (EI) ha sufrido cambios debido a una serie de factores como el envejecimiento, las comorbilidades y los procedimientos médicos. El objetivo de este estudio fue evaluar las principales modificaciones clínicas, epidemiológicas y etiológicas de la EI en los últimos 25 años en Argentina. Se realizó un análisis comparativo de tres registros prospectivos observacionales en los que se incluyeron de forma consecutiva casos de EI definidas y posibles según los criterios de Duke: dos estudios multicéntricos (EIRA-1 [1992-1994] y EIRA-2 [2001-2002]) y un estudio en un centro de referencia de cardiología de tercer nivel (CRC [2007-2017]). En los 1065 episodios de EI evaluados, no existieron diferencias respecto al sexo, y los pacientes fueron más añosos en cada periodo (p < 0.001). La EI asociada a dispositivos intracardiacos fue más frecuente en la última década: infección asociada a marcapasos (5.4 vs. 23% p < 0.0001) y EI de prótesis valvulares (8.5% vs. 19.2% vs. 47.5% p < 0.0001). Por otra parte, la EI asociada a drogas endovenosas (p < 0.0001) y cardiopatías congénitas (p = 0.001) fue significativamente menos frecuente. La etiología cambió sustancialmente: Streptococcus del grupo viridans disminuyó (30.8% vs. 26.8% vs. 15.9%; p < 0.001) y la EI por Staphylococcus spp. predominó por sobre otros microorganismos, con un aumento estadísticamente significativo del Staphylococcus coagulasa negativa (SCN). El tratamiento quirúrgico fue implementado con más frecuencia en la última década y estuvo acompañado de una tendencia a menor mortalidad en el CRC (23.5%, 24.3% vs. 17.2% p = 0.058).

The epidemiology of infectious endocarditis (IE) has undergone changes due to a series of factors such as aging, comorbidities and medical procedures. The aim of this study was to evaluate the main clinical, epidemiological and etiological changes of the IE in the last 25 years in Argentina. A comparative analysis of three observational prospective registries was performed in which cases of definite and possible IE were consecutively included according to the Duke criteria: two multicentre studies (EIRA-1 [1992-1994] and EIRA-2 [2001-2002]) and one study in a reference cardiology center (CRC [2007-2017]). In the 1065 episodes of EI evaluated, there were no differences regarding sex, and the patients were older in each period (p < 0.001). Intracardiac device-associated IE was more frequent in the last decade: pacemaker (5.4 vs. 23% p < 0.0001) and prosthetic valve IE (8.5% vs. 19.2% vs. 47.5% p < 0.0001). On the other hand, IE associated with intravenous drugs (P < 0.0001) and congenital heart diseases (p = 0.001) was significantly less frequent. The etiology changed substantially: Streptococcus viridans group decreased (30.8% vs. 26.8% vs. 15.9%, p < 0.001) and IE by Staphylococcus spp. predominated over other microorganisms, with a statistically significant increase in IE due to coagulase-negative Staphylococcus. Surgical treatment was more frequently implemented in the last decade and was accompanied by a trend towards lower mortality in the CRC (23.5%, 24.3% vs. 17.2% p = 0.058).

Epidemiological and clinical profile of infective endocarditis at a Brazilian tertiary care center: an eight-year prospective study

Abstract INTRODUCTION: Infective endocarditis (IE) is a systemic infectious disease requiring a multidisciplinary team for treatment. This study presents the epidemiological and clinical data of 73 cases of IE in Rio de Janeiro, Brazil. METHODS This observational prospective cohort study of endocarditis patients during an eight-year study period described 73 episodes of IE in 70 patients (three had IE twice). Community-associated (CAIE) and healthcare-acquired infective endocarditis (HAIE) were diagnosed according to the modified Duke criteria. The collected data included demographic, epidemiologic, and clinical characteristics, including results of blood cultures, echocardiographic findings, surgical interventions, and outcome. RESULTS: Analysis of data from the eight-year study period and 73 cases (70 patients) of IE showed a mean age of 46 years (SD=2.5 years; 1-84 years) and that 65.7% were male patients. The prevalence of CAIE and HAIE was 32.9% and 67.1%, respectively. Staphylococcus aureus (30.1%), Enterococcus spp. (19.1%), and Streptococcus spp. (15.0%) were the prevalent microorganisms. The relevant signals and symptoms were fever (97.2%; mean 38.6 + 0.05°C) and heart murmur (87.6%). Vegetations were observed in the mitral (41.1%) and aortic (27.4%) valves. The mortality rate of the cases was 47.9%. CONCLUSIONS: In multivariate analysis, chronic renal failure (relative risk [RR]= 1.60; 95% confidence interval [CI] 1.01-2.55), septic shock (RR= 2.19; 95% CI 1.499-3.22), and age over 60 years (RR= 2.28; 95% CI 1.44-3.59) were indirectly associated with in-hospital mortality. The best prognosis was related to the performance of cardiovascular surgery (hazard ratio [HR]= 0.51; 95% CI 0.26-0.99).

Endocarditis infecciosa en Hospital de Talca, período 1998 - 2015 / Infective endocarditis at Hospital de Talca, 1998-2015

Resumen: Introducción: La endocarditis infecciosa es una enfermedad con una alta mortalidad que se ha mantenido estable en los últimos años pese a avances en su diagnóstico y tratamiento. Objetivo: Evaluar las características clínicas de los pacientes con Endocarditis Infecciosa tratados en el Hospital de Talca. Materiales y métodos: Estudio retrospectivo en que se revisaron las historias clínicas de los pacientes con endocarditis infecciosa atendidos entre 1998 y 2015 en el Hospital Regional de Talca. Resultados: Se encontraron 62 pacientes con endocarditis infecciosa con un promedio de edad de 49,7 años, 61,2% de ellos de sexo masculino, 21% de ellos con válvula protésica y 13% con antecedentes de enfermedad reumática. Las comorbilidades más frecuentes fueron hipertensión arterial, diabetes mellitus y enfermedad renal crónica. El 72,5% de los pacientes se presentaron con síndrome febril y soplo asociado. Un 87,1% presentaban vegetaciones al ecocardiograma. El 67,1% de los pacientes tenía hemocultivo positivo, de los cuales el microorganismo más frecuente fue el Staphylococcus aureus (22,6%). Un 24,2 % de los pacientes requirieron tratamiento quirúrgico. La mortalidad intrahospitalaria fue de un 19,3%. Conclusiones: Las características clínicas de los pacientes descritos son similares a estudios nacionales e internacionales, con una mortalidad intrahospitalaria elevada.

Abstract: Background: Infective endocarditis is a disease with high mortality that remains stable in recent years despite advances in it's diagnosis and treatment. Aim: Evaluate the clinical characteristics of patients with infective endocarditis treated at Hospital de Talca, Chile. Material and Methods: Retrospective study in which the clinical records of patients with infective endocarditis treated between 1998 and 2015 at Hospital Regional de Talca were reviewed. Results: 62 patients with infective endocarditis were identified. The median age was 49,7 years, 61,2% were males. 21% carried one or more prosthetic heart valve and 13% had previous rheumatic valve disease. The most common comorbidities were hypertension, diabetes, and chronic kidney disease. 72,5% presented with fever and a cardiac murmur, 87,1% had vegetations in echocardiography. In 67% of patients blood cultures were positive and22,6% of them had blood cultures positive for Staphylococcus aureus. 24,2 % of patients required hearth surgery. Hospital mortality was 19,3%. Conclusions: The clinical characteristics of patients included in this series were similar to those found in national and international studies, Hospital mortality was high

Microbiota periodontal y microorganismos aislados de válvulas cardiacas en pacientes sometidos a cirugía de reemplazo de válvulas en una clínica de Cali, Colombia / Periodontal microbiota and microorganisms isolated from heart valves in patients undergoing valve replacement surgery in a clinic in Cali, Colombia

Resumen Introducción. La periodontitis es una enfermedad infecciosa que afecta los tejidos de soporte del diente y se asocia con diferentes enfermedades sistémicas, incluida la enfermedad cardiovascular. Los estudios microbiológicos permiten detectar microorganismos a partir de muestras subgingivales y cardiovasculares. Objetivo. Describir la microbiota periodontal cultivable y la presencia de microorganismos en válvulas cardiacas de pacientes sometidos a cirugía de reemplazo valvular en una clínica de Cali. Materiales y métodos. Se analizaron 30 muestras subgingivales y de tejidos valvulares mediante cultivo en medio bifásico, agar de sangre con suplemento y agar tripticasa de soya con antibiótico. Las muestras de las válvulas se analizaron mediante reacción en cadena de la polimerasa (PCR) convencional. Resultados. Los patógenos periodontales aislados de bolsas periodontales fueron Fusobacterium ( 50 % ), Prevotella intermedia/nigrescens (40 %), Campilobacter rectus (40 %), Eikenella corrodens (36,7 %), bacilos entéricos Gram negativos (36,7 %), Porphyromonas gingivalis (33,3 %) y Eubacterium (33,3 %). Los agentes patógenos aislados de la válvula aórtica fueron Propionibacterium acnes (12 %), bacilos entéricos Gram negativos (8 %), Bacteroides merdae (4 %) y Clostridium bifermentans (4 %), y de la válvula mitral, P. acnes y Clostridium beijerinckii. La PCR convencional no arrojó resultados positivos para agentes patógenos orales y solo se detectó ADN bacteriano en dos muestras. Conclusiones. La microbiota periodontal de pacientes sometidos a cirugía de reemplazo valvular estaba conformada por especies Gram negativas que han sido relacionadas con infecciones en tejidos extraorales; sin embargo, no se encontraron agentes patógenos periodontales en los tejidos de las válvulas. Aunque hubo muestras de estos tejidos y subgingivales, positivas para bacilos entéricos Gram negativos, no es posible asegurar que tuvieran el mismo origen filogenético.

Abstract Introduction: Periodontitis is an infectious disease that affects the support tissue of the teeth and it is associated with different systemic diseases, including cardiovascular disease. Microbiological studies facilitate the detection of microorganisms from subgingival and cardiovascular samples. Objective: To describe the cultivable periodontal microbiota and the presence of microorganisms in heart valves from patients undergoing valve replacement surgery in a clinic in Cali. Materials and methods: We analyzed 30 subgingival and valvular tissue samples by means of twophase culture medium, supplemented blood agar and trypticase soy agar with antibiotics. Conventional PCR was performed on samples of valve tissue. Results: The periodontal pathogens isolated from periodontal pockets were: Fusobacterium nucleatum (50%), Prevotella intermedia/ nigrescens (40%), Campylobacter rectus (40%), Eikenella corrodens (36.7%), Gram negative enteric bacilli (36.7%), Porphyromonas gingivalis (33.3%), and Eubacterium spp. (33.3%). The pathogens isolated from the aortic valve were Propionibacterium acnes (12%), Gram negative enteric bacilli (8%), Bacteroides merdae (4%), and Clostridium bifermentans (4%), and from the mitral valve we isolated P. acnes and Clostridium beijerinckii. Conventional PCR did not return positive results for oral pathogens and bacterial DNA was detected only in two samples. Conclusions: Periodontal microbiota of patients undergoing surgery for heart valve replacement consisted of species of Gram-negative bacteria that have been associated with infections in extraoral tissues. However, there is no evidence of the presence of periodontal pathogens in valve tissue, because even though there were valve and subgingival samples positive for Gram-negative enteric bacilli, it is not possible to maintain they corresponded to the same phylogenetic origin.

Un brote epidémico de endocarditis por Pseudomonas aeruginosa secundario a angiografía coronaria / An outbreak of Pseudomonas aeruginosa infective endocarditis subsequent to coronary angiography

Objectives: To describe an endocarditis outbreak affecting three patients due to Pseudomonas aeruginosa infection post coronary angiography performed in the Cardiovascular Surgery and Cardiology Medical Center of a private hospital. Methods: After recognition of an infection cluster within a onemonth period, the outbreak was reported to Antalya Department of Health and a broad investigation was initiated in order to determine the most probable cause and/or source of nosocomial pseudomonal endocarditis. Patient data were obtained by medical record review as well as interviews with patients or their next of kin. Thirty-six surveillance samples for P. aeruginosa were collected from various locations within the coronary angiography unit. The outbreak research team reviewed the private hospital's Cardiovascular Surgery and Cardiology Medical Center's infection control procedures. The epidemiology of P. aeruginosa was studied through analysis of phenotypic markers, including antimicrobial sensitivity profiles. Results: The infection control audit revealed multiple breaches of infection control procedures. Only 1/36 environmental samples yielded, which was isolated from a radio-opaque solution within an angiography injector pump. P. aeruginosa from the radio-opaque solution had an identical antimicrobial susceptibility pattern to the strain isolated from patients. Both samples were susceptible to all antipseudomonal agents. This outbreak could have been successfully controlled by instituting combined infection control measures. Conclusions: This outbreak emphasizes the important of adherence to infection control standards and practices for cardiac catheterization, as well as the need for closer collaboration between the Infection Control Committee and coronary angiography personnel.

Objetivos: Describir un brote de endocarditis por Pseudomonas aeruginosa que afectó a tres pacientes tras habérseles efectuado una coronariografía en el Centro Médico de Cardiología y de Cirugía Cardiovascular (CMC-CCV) de un hospital privado. Métodos: Después de reconocer la aparición de un brote en un periodo de un mes, este hecho fue comunicado al Departamento de Salud de Antalya, iniciándose una exhaustiva investigación para precisar la más probable causa y/o fuente de las endocarditis nosocomiales. Se extrajo de los registros médicos los datos clínicos de los pacientes y se efectuaron entrevistas a los pacientes o sus familiares. Se extrajo 36 muestras medioambientales de vigilancia en busca de P. aeruginosa de diversos sitios dentro de la unidad de coronariografía. Un team que investigó el brote revisó los procedimientos en uso para la prevención de infecciones en el CMC-CCV. Se estudió la epidemiología de la P. aeruginosa mediante análisis de su fenotipos, incluyendo el perfil de susceptibilidad in vitro a antimicrobianos. Resultados: La auditoria comprobó el quiebre de diversas normas de control de infecciones. Sólo 1/36 de las muestras ambientales arrojó el cultivo de P. aeruginosa, a partir de una solución de medio radio-opaco dentro de una bomba inyectora empleada en las angiografías. Los aislados de P. aeruginosa desde la solución del medio radio-opaco tenían idéntico patrón de susceptibilidad antimicrobiana que las cepas recuperadas de los pacientes. Ambos tipos de muestras eran susceptibles a todos los antimicrobianos con actividad anti-pseudomonas. El brote pudo evitarse si se hubieran instaurado una serie de medidas de control de infecciones. Conclusiones: Este brote enfatiza la importancia de adherir a los estándares y prácticas de control de infecciones para la cateterización cardiaca, así como la necesidad de una estrecha colaboración entre el Comité de Control de Infecciones y el personal involucrado en el procedimiento de coronariografía.

Endocarditis por Brucella canis: primer caso documentado en un paciente adulto en Argentina / [Brucella canis endocarditis: first documented case in Argentina].

We herein present the case of an adult male patient who consulted for lower extremity edema, a 2- month history of fever and oppressive chest pain radiating to the left arm. He referred neither contact with breeding animals nor consumption of unpasteurized dairy products. A diagnosis of endocarditis was confirmed by cardiac studies. Since the empirical treatment with cephalotin, ampicillin and gentamicin failed, the patient underwent aortic valve replacement. A total of four blood cultures were positive with a gram-negative rod. Bacterial identification was performed using the API 20 NE technique (bioMÞrieux), the Phoenix automated method (BD) and conventional biochemical tests which were unable to classify the isolate as to genus and species. The strain was sent to the INEI-ANLIS "Dr. Carlos G. Malbrán" where it was identified as Brucella canis. The antimicrobial treatment was switched to doxycycline, rifampicin and trimethoprim-sulfamethoxazole with good evolution of the patient. The clinical significance of this case report lies in the possible failure of the empiric antibiotic therapy administered for endocarditis, since B. canis did not respond to the conventional antimicrobial treatment for this pathology.

Actualización sobre endocarditis infecciosa en válvula protésica / Up-date in prosthetic valve endocarditis

La endocarditis en válvulas protésicas es aún tema de controversia, en especial en referencia al tipo de tratamiento que se debe elegir. Debido a que los conocimientos actuales sobre esta patología están basados principalmente en la literatura y por ende, en sus variados exponentes (experiencias clínicas, revisiones sistemáticas, guía clínicas de diferentes sociedades de cardiología, estudios observacionales, entre otros), es necesario hacer una actualización continua de la información. Esta revisión bibliográfica se centra en la incidencia, etiología, diagnóstico y tratamiento de la endocarditis protésica. En ella se llega la conclusión de que los principales microorganismos productores de esta patología son el Estafilococo aureus y el Estafilococo coagulasa-negativo. También se reconocen aquellos factores de riesgo para los cuales la cirugía es mandatoria, entre los que destacan las infecciones por S. aureus y la endocarditis protésica complicada, ya sea por insuficiencia cardíaca, alteración de la conducción, formación de abscesos y/o embolias recurrentes. De esta manera, con la información recopilada, se identificaron aquellos pacientes con opción a tratamiento médico, y aquellos con indicación de manejo quirúrgico. Para presentar mejor nuestras conclusiones, se construyeron esquemas de fácil consulta y lectura, para apoyar la decisión del tipo de manejo frente a una endocarditis en válvulas protésicas.

Prosthetic valve endocarditis is still a matter of controversy especially the type of treatment that should be chosen for an individual patient. Since the current knowledge of this pathology is based mainly on the literature and in its many and varied exponents (clinical experience, systematic review, practice guidelines of cardiology associations, observational studies, etc), it is necessary to update the information continuously This review is focused mainly in the incidence, etiology diagnostics and treatment of prosthetic endocarditis. The principal microroganisms related to this pathology are Staphylococcus aureus and coagulase-negative Staphyloccoco. Risk factors were identified for witch surgery is mandatory, such us Staphylococcus aureus infection and a complicated prosthetic valve endocarditis (cardiac failure, conduction abnormalities, abscess formation and recurrent embolism). With this information, patients that could have a medical treatment option can be recognized, as well as those who will require surgery. In order to present in a better way our conclusions, easily reading diagrams were included to facilitate the decision process when facing up a prosthetic valve endocarditis.

O que há de novo na profilaxia da endocardite bacteriana. Deve-se mudar a conduta atual? / What?s new in the prophylaxis of bacterial endocarditis. We must change our current practice?

JUSTIFICATIVA E OBJETIVOS: A endocardite é uma doença em que agentes infecciosos invadem as superfícies endocárdicas, produzindo inflamação e lesões. Sendo muito discutida após a publicação das diretrizes da American Heart Association de 2007. Tais diretrizes têm causado muitas controvérsias na literatura atual, com reflexo na decisão quanto à conduta a ser adotada para sua profilaxia. Dessa forma, este estudo teve por objetivo contribuir na prática clínica, no tocante a real indicação e custo efetividade da profilaxia antimicrobiana para a prevenção da endocardite bacteriana. CONTEÚDO: Este estudo versa sobre a profilaxia da endocardite bacteriana, através de uma revisão da literatura e seus conceitos mais relevantes, discutindo o consenso americano e sua aplicabilidade na realidade brasileira. Para tanto foram feitas duas pesquisas na base de dados da PubMed, Sociedade Brasileira de Cardiologia e Sociedade Brasileira de Odontologia. CONCLUSÃO: A escolha da profilaxia antibiótica deve levar em conta os aspectos atuais de nossa população, bem como a classificação de risco para endocardite e a evolução clínica de cada paciente na prática diária, para uma correta indicação do antibiótico e melhora de seu custo efetividade.

Prevalence and outcome of bacterial endocarditis in patients with implantable cardiac device infections

Cardiac device infection [CDI] is a devastating complication of permanent pacemaker [PPM] or implantable cardioverter-defibrillators [ICD]. The incidence and outcome of endocarditis among patients with CDI is not well defined. The aim of this study was to report our experience in the prevalence, clinical presentations, and management of bacterial endocarditis [BE] among patients with CDI in a tertiary care cardiac center over a 25-year period. A total of 2630 cardiac devices implanted in a cohort of 2367 patients over 25 years were studied. Of these, 117 [4.4%] patients presented with CDI. Clinical, bacteriologic and both transthoracic [TTE] and transoesophageal echocardiographic [TEE] assessment were done. Of the 117 patients with CDI [90 males, age range 18-82 yrs, mean = 63 +/- 6 yrs], 87 [74%] had redo procedures [battery replacement in 50, repositioning of leads in 12, device extrusion in 15 or evacuation of significant haematoma in 10 patients]. Of these 87 patients, 65 had -re-implants on the same day of explantation. In 30 patients [26%] no apparent cause of PI was identified. Of the 117 patietns with CDI, 30 patients [26% of CDI and 1.1% of total procedures] had device-related BE with vegetations having appeared in all patients by TEE [15 DDD, 9VVI, 3 CRT and 3 ICD]. The clinical presentations were prolonged fever in 25 patients [83%], significant pulmonary hypertension with thrombo-embolism in 3 patients [10%], severe sepsis and multi-organ failure in 2 patients [6%]. Twenty-eight patients [93%] had positive blood cultures [S aureus in 23 [77%] and enterococci in 5]. There were only 2 patients with negative blood cultures. Device lead vegetations were evident in 20 patients [>10 mm diameter in 13 patients]. Ten patients presented with only right heart valve vegetations. Of the 30 BE patients, 28 [93%] had PI while 2 patients had no apparent cause but frequent intravenous injections [one drug addict and one on regular haemodialysis]. Of the 20 patients with lead endocarditis, 15 had their leads removed surgically with re-implantation of either epicardial [6 patients] or endocardial leads [9 patients]. Fifteen patients had only medical treatment with proper antibiotics [5 patients with lead BE and all 10 patients with valvular BE]. Four patients [13%] died; all had their devices implanted on same day of explanation. Cardiac device redo procedures are major risk factors for CDI, especially with re-implantation on the same day. Device related BE carries a serious morbidity and mortality, yet surgical removal of the whole system in the management of choice. Blood stream bacteraemia is a potential risk factor in patients with cardiac devices and warrants prophylaxis against BE

[Infective endocarditis on probe of pacemaker]

Infective endocarditis is an uncommon but potentially lethal complication of permanent cardiac pacing. Infection is mainly caused by local contamination during the implantation procedure. The most frequently detected causative microorganisms were staphylococci. The clinical presentation is often atypical causing prolonged diagnostic delay. Bacteriological data and visualisation of neostructures consistent with vegetations on transoesophageal echocardiography, strongly suggest pacemaker lead infection. Management is based on a combined approach using both prolonged antibiotic treatment and early complete device explantation. Percutaneous techniques are currently the method of choice for lead extraction but it is not without possible complications. Antibiotic prophylaxis in order to reduce infection risk related to pacemaker implantation is widely recommended

First reported case of infective endocarditis caused by community-acquired methicillin-resistant Staphylococcus aureus not associated with healthcare contact in Brazil

We report here the first case of endocarditis due to CA-MRSA not associated with healthcare contact in Brazil in Brazil. A previously healthy patient presented with history of endocarditis following a traumatic wound infection. Patient had multiple positive blood cultures within 72 h of admission and met modified Duke's criterion for infective endocarditis. The isolate was typed as Staphylococcal cassette chromosome (SCC) mec type IV and was positive for presence of Panton-Valentine leukocidin (PVL). Increased incidence of CA-MRSA endocarditis is a challenge for the internist to choose the best empirical therapy. Several authors have suggested an empirical therapy with both a beta-lactam and an anti-MRSA agent for serious S. aureus infections. Our patient was treated with Vancomycin and made complete recovery in 3 months.

Estudio retrospectivo de la endocarditis infecciosa en diferentes grupos de riesgo / Infective endocarditis in an internal medicine ward

Background: Due to the increasing number of intravenous drug users, subjects with immune deficiencies or with prosthetic valves, infective endocarditis (IE) continues to be prevalent and to have a high mortality. Aim: To review all cases of infective endocarditis diagnosed in an Internal Medicine Service. Material and methods: Retrospective review of medical records of all patients with infective endocarditis, hospitalized in an Internal Medicine ward, between 1989 and 2003. Dukes criteria were used to define definitive, possible and less probable cases of IE. Results: Eighty seven patients with definite IE were identified (66 males, age range 19-84 years), with a mean incidence of 5.3 per 1000 hospitalizations. IE in intravenous drugs users was usually caused by Staphylococcus aureus and presented high risk of embolism (RR: 3,21). Subjects aged over 70 years had a relative risk of mortality of 5.5. Hospital acquired IE was associated with advanced age and IV catheters appeared as the only predisposing factor. Patients with prosthetic valves were also older, their main complication was abscess formation and their mortality was higher. Conclusions: A closer approach to differential conditions of patients, according to age, intravenous drug use or the presence of prosthetic valves, is necessary

Endocarditis infecciosa por S. aureus en la Argentina: EIRA 2. Análisis comparativo luego de 10 años de los estudios EIRA 1 y 2 / S. aureus infective endocarditis in Argentina: a comparative analysis after 10 years of EIRA-1 and EIRA-2 surveys

Objetivo: Comparar el perfil y la evolución de la endocarditis infecciosa (EI) en nuestro país a lo largo de 10 años, a través de los registros EIRA-1 y EIRA-2. Determinar las características clínicas y epidemiológicas y la evolución hospitalaria de la EI por Staphylococcus aureus (EISA) en la Argentina. Métodos: El estudio EIRA-2 fue un registro prospectivo multicéntrico conducido en 82 hospitales de 16 provincias de la Argentina. En el presente análisis se incluyeron pacientes con EI definidas (clasificación de Duke) relevados en un período de 18 meses. Resultados: Se registraron 390 episodios de EI definidas (108 EISA y 282 no EISA); edad media 58,5 ± 17,3 años, sexo masculino 70 por ciento. No existieron diferencias estadísticamente significativas entre las 108 EISA y las 282 no EISA con respecto a edad, sexo, endocarditis de válvula protésica, enfermedad valvular degenerativa, presencia de insuficiencia cardíaca y frecuencia de tratamiento quirúrgico. La comparación de los registros EIRA-2 y EIRA-1 demostró cambios importantes en el perfil de la enfermedad en la última década, actualmente caracterizada por pacientes de mayor edad (58 versus 51 años), mayor prevalencia de cardiopatía subyacente 67 por ciento versus 55 por ciento (en particular prótesis valvulares 19,2 por ciento versus 8,5 por ciento, enfermedades valvulares degenerativas 12,4 por ciento versus 4,8 por ciento y cardiopatías congénitas 9,5 por ciento versus 4,2 por ciento), mayor frecuencia de infección causada por S. aureus (30 por ciento versus 26 por ciento) y menor por Streptococcus viridans (30,8 por ciento versus 26,8 por ciento), con una reducción del tiempo hasta el diagnóstico definitivo (21,5 versus 33 días). No se encontraron modificaciones en la tasa de mortalidad de la enfermedad. Se observó una diferencia estadísticamente significativa (p < 0,01) de las EISA con respecto a las no EISA en la prevalencia de cardiopatía subyacente [58,3 por ciento versus 67,4 por ciento (OR 0,7